Glenmark Pharmaceuticals Rating Buy: Domestic Growth To Stand Out | Latest News RSS feed

Glenmark Pharmaceuticals Rating Buy: Domestic Growth To Stand Out - Latest News

Glenmark Pharmaceuticals rating ‘buy’: Domestic growth to stand out

FY19 EPS up 22% even as FY20F EPS is cut 14.9% due to expenses; TP raised to Rs 850 We expect Glenmark Pharmaceuticals’ (GNP’s) domestic formulation to sustain growth ahead of the broader market. GNP ... read more

Markets: Sensex gains 227 points to close at 37,318

Glenmark Pharmaceuticals on Tuesday said it has received final ... arriving at a target price of ₹1,465/share (+31 per cent upside). We maintain our ‘buy’ rating. China's offshore yuan hit a fresh ... read more

April buys: Sobha, HDFC AMC among 10 stocks that brokerages are betting on

We initiate coverage on CFH and assign a 'buy' rating ... growth in non-MFI portfolio along with healthy growth in MFI book. Post bottoming out in FY18, its RoAs is expected to cross 2 percent levels ... read more

Looking for another news?

The Vanishing Mass Market

The mass media's decline is an old story in many respects; prime-time network ratings and newspaper circulation have ... "Merely describing a product's attributes once was enough to make it stand out ... read more

Aurora Cannabis (ACB) and Canopy (CGC) Likely to Remain Leaders in the Cannabis Space, But There Are Better Value Stocks

“Accordingly, Marcato believes it is highly imprudent for Acreage to sell itself today at the proposed valuation, with so much unlocked growth ... out at C$76.88. (See CGC’s price targets and analyst ... read more

Mediaset SpA (MDIEF) Management on Q1 2019 Results - Earnings Call Transcript

But, I'd like to focus on gross domestic product dynamics combined with ... This slight negative trend at the end of last year turns out into minus 3.5% slow start trend in Q1. ... read more

Q3 winners: 10 companies that are likely to double their profit YoY

We have collated a list of top 10 stocks from different brokerage firms that are likely to more than double their net profit year-on-year in the December quarter: Glenmark Pharma ... crore Motilal ... read more

Ireland’s GDP figures: Why 26% economic growth is a problem

Everybody knows that the 26 per cent plus growth ... out of more obvious tax havens and into low-tax jurisdictions such as Ireland, massively boosting the State’s capital assets. Investment in ... read more

Sensex recovers to end flat at 39,031

Drug major Glenmark Pharma on ... on strong gross domestic product data, which grew at 3.2 per cent in January-March period this year. Foreign institutional investors (FIIs) emerged net sellers in the ... read more

Tax reform fallout: Bank, media and retail stocks poised to cash in

Technology is the one sector that looks scary, with its high amount of international sales and a possible trend where investors would sell their gains to buy ... out but we think it has further to go. ... read more

The top 10 films at the Chinese box office, and the five biggest flops, in 2018

If that sounds like good news, the reality is that growth in box office takings in China appears ... It was rated only 3.9 out of ten on Chinese film rating site Douban. In spite of its plentiful ... read more

Abbott: Triumph Upon Triumph

I currently count it as a stalwart in my long-term dividend growth stock portfolio. While I am absolutely comfortable holding my current position, I do not expect to buy more ... to stand pat. That ... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us